BD PharmingenTM Alexa FluorTM 647 Biosimilar Anti-Human CD52

Description

Multiparameter flow cytometric analysis of CD52 Alemtuzumab Biosimilar expression on Human peripheral blood leukocyte populations. Human whole blood was stained with either Alexa Fluor 647 Human IgG1, kappa Isotype Control Cat. No. 569961; Left Plot or Alexa Fluor 647 Biosimilar Anti-Human CD52 antibody Cat. No. 571184/571185; Right Plot . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The bivariate pseudocolor density plot showing the correlated expression of CD52 Alemtuzumab Biosimilar or Ig Isotype control staining versus side light-scatter SSC-A signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Multiparameter flow cytometric analysis of CD52 Alemtuzumab Biosimilar expression on Human peripheral blood leukocyte populations. Human whole blood was stained with either Alexa Fluor 647 Human IgG1, kappa Isotype Control Cat. No. 569961; Left Plot or Alexa Fluor 647 Biosimilar Anti-Human CD52 antibody Cat. No. 571184/571185; Right Plot . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The bivariate pseudocolor density plot showing the correlated expression of CD52 Alemtuzumab Biosimilar or Ig Isotype control staining versus side light-scatter SSC-A signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Multiparameter flow cytometric analysis of CD52 Alemtuzumab Biosimilar expression on Human peripheral blood leukocyte populations. Human whole blood was stained with either Alexa Fluor 647 Human IgG1, kappa Isotype Control Cat. No. 569961; Left Plot or Alexa Fluor 647 Biosimilar Anti-Human CD52 antibody Cat. No. 571184/571185; Right Plot . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The bivariate pseudocolor density plot showing the correlated expression of CD52 Alemtuzumab Biosimilar or Ig Isotype control staining versus side light-scatter SSC-A signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Show More Multiparameter flow cytometric analysis of CD52 Alemtuzumab Biosimilar expression on Human peripheral blood leukocyte populations. Human whole blood was stained with either Alexa Fluor 647 Human IgG1, kappa Isotype Control Cat. No. 569961; Left Plot or Alexa Fluor 647 Biosimilar Anti-Human CD52 antibody Cat. No. 571184/571185; Right Plot . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The bivariate pseudocolor density plot showing the correlated expression of CD52 Alemtuzumab Biosimilar or Ig Isotype control staining versus side light-scatter SSC-A signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Show More Multiparameter flow cytometric analysis of CD52 Alemtuzumab Biosimilar expression on Human peripheral blood leukocyte populations. Human whole blood was stained with either Alexa Fluor 647 Human IgG1, kappa Isotype Control Cat. No. 569961; Left Plot or Alexa Fluor 647 Biosimilar Anti-Human CD52 antibody Cat. No. 571184/571185; Right Plot . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The bivariate pseudocolor density plot showing the correlated expression of CD52 Alemtuzumab Biosimilar or Ig Isotype control staining versus side light-scatter SSC-A signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Multiparameter flow cytometric analysis of CD52 Alemtuzumab Biosimilar expression on Human peripheral blood leukocyte populations. Human whole blood was stained with either Alexa Fluor 647 Human IgG1, kappa Isotype Control Cat. No. 569961; Left Plot or Alexa Fluor 647 Biosimilar Anti-Human CD52 antibody Cat. No. 571184/571185; Right Plot . Erythrocytes were lysed with BD Pharm Lyse Lysing Buffer Cat. No. 555899 . The bivariate pseudocolor density plot showing the correlated expression of CD52 Alemtuzumab Biosimilar or Ig Isotype control staining versus side light-scatter SSC-A signals was derived from gated events with the forward and side light-scatter characteristics of viable leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software.